2X MATCH: 2X MATCH Today, your gift is DOUBLED for 2X the impact on lifesaving research.
Clear Search

Hedvig Hricak, MD, PhD

Memorial Sloan Kettering Cancer Center
New York, New York

Titles and Affiliations

Chair, Department of Radiology
Molecular Pharmacology Program, Sloan Kettering Institute
Professor, Gerstner Sloan Kettering Graduate School of Biomedical Sciences
Professor, Radiology, Weill Cornell Medical College, Cornell University

Research area

Advancing the clinical management of breast cancer worldwide through radiology research and training.

Impact

Radiologists play a crucial role not just in detecting breast cancer and monitoring cancer response to therapy, but also in breast cancer care—from image-guided breast cancer surgery to treatment interventions. However, radiologists working in low resource settings may not have access to the latest technology or be familiar with current advances in screening and treatments. Dr. Hricak leads a research training program that has educated breast imaging radiologists from 20 countries, enabling these specialists to conduct research and deliver the best imaging care in their communities.

Progress Thus Far

Dr. Hricak and her colleagues in the department of radiology at Memorial Sloan Kettering Cancer Center continue to expand their clinical research training program, which is now in its 18th year. Thus far, they have trained 55 radiologists from around the world in the use of advanced technologies for breast imaging. Recently, Dr. Hricak and her team completed collaborative work with members of the Medical Imaging and Nuclear Medicine Lancet Oncology Commission showing that the diagnosis and treatment of patients with cancer requires access to imaging to ensure accurate management decisions and optimal outcomes. Their global assessment of imaging and nuclear medicine resources identified substantial shortages in equipment and workforce, particularly in low-income and middle-income countries.

What’s next

Dr. Hricak and her team will continue to mentor radiologists from Europe, and Central and South America. The fellowship program’s focus, however, is now shifting to provide onsite training to physicians from Sub-Saharan Africa in line with results from The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine. In the first pilot year of this program, Dr. Hricak’s team will onboard physicians from Sub-Saharan Africa at Memorial Sloan Kettering Cancer Center and provide training in breast imaging, multidisciplinary breast cancer care, and clinical research. These physicians will then train physicians in their home countries to further increase and strengthen the cancer workforce and the practice of clinical research. Providing training to enhance the workforce will help contribute to reducing the dramatic disparity in breast cancer outcomes that exists today between high-income countries and those in sub-Saharan Africa.

Biography

Hedvig Hricak is Chair of the Department of Radiology, Memorial Sloan Kettering Cancer Center, a member of the Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, and Professor, Gerstner Sloan Kettering Graduate School of Biomedical Sciences. The hallmark of her research career has been the validation of new imaging technologies and their translation into clinical practice, with a special emphasis on oncology. She is particularly renowned for pioneering the application of MRI to prostate and gynecological cancers. Her extensive publication record includes more than 380 peer-reviewed original research articles and over 135 monographs and book chapters. She is a member of the Institute of Medicine of the National Academy of Sciences and a “foreign” member of the Croatian Academy of Arts and Sciences and the Russian Academy of Science. She has served on the Scientific Advisory Board of the National Cancer Institute, the Advisory Council of the National Institute of Biomedical Imaging and Bioengineering, and the Nuclear and Radiation Studies Board of the NAS. She has long been committed to promoting education and international collaboration in imaging. With support from BCRF and NCI, she established a global program for training in breast cancer imaging and research. She is also PI of the NIH/NCI R25T program “Molecular Imaging: Training for Oncology,” as well as MSKCC co-PI of the training section of the CCNY-MKSCC Partnership grant for underrepresented undergraduate and graduate students and postdoctoral trainees. Her numerous honors and awards include an honorary doctorate from the Ludwig Maximilian University, Munich.

BCRF Investigator Since

2004

Donor Recognition

The Lifetime Network Award

Areas of Focus

Treatment Tumor Biology